Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 16, 2024, titled "Press Release for grant of USFDA Approval".
Caplin Point Laboratories Limited has informed the Exchange regarding a press release dated December 16, 2024, titled "Press Release for grant of USFDA Approval".